Task: Answer the multiple-choice question.
Query: Which compound exhibits a -33.706% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a CCN1C(=O)/C(=C/C2=Cc3ccccc3OC2C)SC1=S
b CNC(=O)N(C1=NCC(C)(C)S1)c1ccc(F)c(Cl)c1
c CCOc1ccc(N2CC(C(=O)Nc3cccc(C)c3C)CC2=O)cc1
d COCCCNC(=O)c1cn(C)c(=O)c2cc(OC)c(OC)cc12
e O=[N+]([O-])c1ccc(/C=C2\CCC(C3=CCCC3)=C2N2CCOCC2)cc1
Answer: e. O=[N+]([O-])c1ccc(/C=C2\CCC(C3=CCCC3)=C2N2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=[N+]([O-])c1ccc(/C=C2\CCC(C3=CCCC3)=C2N2CCOCC2)cc1
O=[N+]([O-])c1ccc(/C=C2\CCC(C3=CCCC3)=C2N2CCOCC2)cc1
4-[(5E)-2-(cyclopenten-1-yl)-5-[(4-nitrophenyl)methylidene]cyclopenten-1-yl]morpholine